These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16386655)

  • 1. Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil.
    Naud P; Matos J; Hammes L; Stuckzynski J; Brouwers K; Magno V; Dias E; Crusius P; d'Avila A; Campos C; Costa M; Höblik M; Marc C; Marroni R; Syrjänen K
    Eur J Obstet Gynecol Reprod Biol; 2006 Jan; 124(1):110-8. PubMed ID: 16386655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J
    Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine.
    Ault KA; Giuliano AR; Edwards RP; Tamms G; Kim LL; Smith JF; Jansen KU; Allende M; Taddeo FJ; Skulsky D; Barr E
    Vaccine; 2004 Aug; 22(23-24):3004-7. PubMed ID: 15297048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization.
    Bollen LJ; Chuachoowong R; Kilmarx PH; Mock PA; Culnane M; Skunodom N; Chaowanachan T; Jetswang B; Neeyapun K; Asavapiriyanont S; Roongpisuthipong A; Wright TC; Tappero JW
    Sex Transm Dis; 2006 Apr; 33(4):259-64. PubMed ID: 16452834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial.
    Gudmundsdóttir T; Tryggvadóttir L; Allende M; Mast TC; Briem H; Sigurdsson K
    Acta Obstet Gynecol Scand; 2003 Apr; 82(4):345-50. PubMed ID: 12716319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of knowledge and attitudes of young uninsured women toward human papillomavirus vaccination and clinical trials.
    Moreira ED; de Oliveira BG; Neves RC; Costa S; Karic G; Filho JO
    J Pediatr Adolesc Gynecol; 2006 Apr; 19(2):81-7. PubMed ID: 16624694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India.
    Berlin Grace VM
    Indian J Cancer; 2009; 46(3):203-7. PubMed ID: 19574671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular testing of human papillomavirus in cervical specimens.
    Gazzaz FB
    Saudi Med J; 2007 Dec; 28(12):1810-8. PubMed ID: 18060207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S; Alain S; Denis F
    Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
    Dondog B; Clifford GM; Vaccarella S; Waterboer T; Unurjargal D; Avirmed D; Enkhtuya S; Kommoss F; Wentzensen N; Snijders PJ; Meijer CJ; Franceschi S; Pawlita M
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1731-8. PubMed ID: 18628425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
    Wheeler CM
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions.
    Coutlée F; Trottier H; Gagnon S; Koushik A; Richardson H; Roger M; Ferenczy AS; Franco EL
    J Clin Virol; 2009 Jun; 45(2):96-9. PubMed ID: 19398216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
    Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
    J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16/18) vaccine clinical trials.
    Paavonen J;
    Curr Med Res Opin; 2008 Jun; 24(6):1623-34. PubMed ID: 18435868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.